Deuterated benzylaminopyrimidinedione derivatives and use thereof
AssigneeQingdao JiãO Pharmaceutical Technology Co., Ltd
InventorChanglun Shao
Life of this patent
Estimating the term…
Abstract
The present invention discloses deuterated benzylaminopyrimidinedione derivatives, the use thereof and the pharmaceutical composition containing the same. They may be used for suppressing the activities of myosin. The present invention also relates to the method of preparing this type of compounds and the pharmaceutical composition, and their use in treatment of hypertrophic cardiomyopathy and related heart diseases.
Claims11
A compound, wherein the compound is a compound represented by Formula I, or a stereoisomer, a geometric isomer, a tautomer, an oxynitride, a hydrate, a solvate, a metabolite, a pharmaceutical acceptable salt or a prodrug of the compound represented by Formula I,
- wherein
- R1 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms, wherein the C1-6 alkyl, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms are independently not substituted or substituted by 1, 2, 3, or 4 Rx, respectively;
- R2 is selected from the group consisting of C1-6 alkyl, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms, wherein the C1-6 alkyl, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms are independently not substituted or substituted by 1, 2, 3, or 4 Ry, respectively;
- R3, R4, R5 and R6 are each independently selected from the group consisting of H, D, F, Cl, Br, I, CN, NO2, OH, NH2, SH, C1-6 alkyl, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylamino, C1-6 alkoxy, —C(═O)Rg, —C(═O)ORh, —S(═O)2Rg, —C(═O)NRiRj, —S(═O)2NRiRj, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms, wherein OH, NH2, SH, C1-6 alkyl, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylamino, C1-6 alkoxy, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms are independently not substituted or substituted by 1, 2, 3, or 4 Rz, respectively;
- and
- R7 is selected from the group consisting of H, D, F, Cl, Br, I, C1-6 alkyl and C1-6 haloalkyl,
- wherein Rx, Ry and Rz are each independently selected from the group consisting of D, F, Cl, Br, I, CN, NO2, OH, NH2, SH, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkylamino, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl, heteroaryl composed of 5-10 atoms, —(CRaRb)nR0, —ORc, —C(═O)Rd, —C(═O)ORc, —S(═O)2Rd, —C(═O)NReRf and —S(═O)2NReRf,
- wherein Ra and Rb are each independently selected from the group consisting of H, C1-6 alkyl and C1-6 haloalkyl;
- R0 is each independently selected from the group consisting of C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms;
- Rc, Re, Rf, Rh, Ri and Rj are each independently selected from the group consisting of H, D, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms;
- or Re, Rf and a nitrogen atom attached to them form a heterocyclyl composed of 3-8 atoms or a heteroaryl composed of 5-10 atoms;
- Rd and Rg are each independently selected from the group consisting of H, OH, NH2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkylamino, C1-6 alkoxy, C3-8 cycloalkyl, heterocyclyl composed of 3-8 atoms, C6-10 aryl and heteroaryl composed of 5-10 atoms;
- and
- n is each independently 1, 2, 3 or 4.
A compound, wherein the compound is a compound in one of following structures, or a stereoisomer, a geometric isomer, a tautomer, an oxynitride, a hydrate, a solvate, a metabolite, a pharmaceutical acceptable salt or a prodrug of the compound in one of following structures:
-12. (canceled)
Dependencies are inferred from the claim text.